Last 12 months
Inside the activity.
1 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 30 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2016 Filed Nov 16, 2016 16:12 UTC |
Murphy Brian MDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 183,359 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001144204-16-134957 · v453304_4.xml · derivative · entry 1 Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,359 Underlying: Common Stock · 183,359 shares Expires 2026-11-14 F1 · derivative.exercise_date: On November 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer. F1 · balance_after: On November 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer. Read SEC document |
| October 19, 2016 Filed Oct 20, 2016 20:09 UTC |
Stern WilliamDirector · President
|
GrantOption to Purchase Common Stock · Derivative | 35,000 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001144204-16-128814 · v450896_4.xml · derivative · entry 1 Stern William · CIK 0001607801 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-10-19 Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 15:38 UTC |
FASHEK CHRISTOPHER MDirector
|
GrantOption to Purchase Common Stock · Derivative | 91,679 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001144204-16-128481 · v450726_4.xml · derivative · entry 1 FASHEK CHRISTOPHER M · CIK 0001279063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,679 Underlying: Common Stock · 91,679 shares Expires 2026-10-14 F1 · derivative.exercise_date: On October 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer. F1 · balance_after: On October 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.